LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Joint cracking and popping: understanding noises that accompany articular release.

    Protopapas, Marina G / Cymet, Tyler C / Protapapas, Marina G

    The Journal of the American Osteopathic Association

    2002  Volume 102, Issue 5, Page(s) 283–287

    Abstract: Articular release is a physiologic event that may or may not be audible. It is seen in patients with healthy joints as well as those with somatic dysfunction. After an articular release, there is a difference in joint spacing-with the release increasing ... ...

    Abstract Articular release is a physiologic event that may or may not be audible. It is seen in patients with healthy joints as well as those with somatic dysfunction. After an articular release, there is a difference in joint spacing-with the release increasing the distance between articular surfaces. Not all noise that emanates from a joint signifies an articular release. A hypothesis about the noise that frequently accompanies this release is offered and includes anatomic, physiologic, and functional models of articular release. Repeated performance of articular release may decrease the occurrence of arthritis. Potential problems from repeated articular release (eg, hypermobility) are also examined.
    MeSH term(s) Humans ; Joint Diseases/therapy ; Manipulation, Osteopathic/methods ; Musculoskeletal Diseases/therapy ; Range of Motion, Articular/physiology ; Sensitivity and Specificity ; Severity of Illness Index ; Sound
    Language English
    Publishing date 2002-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 410350-6
    ISSN 1945-1997 ; 0098-6151 ; 0003-0287
    ISSN (online) 1945-1997
    ISSN 0098-6151 ; 0003-0287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The complications of scar formation associated with intrathecal pump placement.

    Protopapas, Marina G / Bundock, Elizabeth / Westmoreland, Susan / Nero, Christopher / Graham, W Andrew / Nesathurai, Shanker

    Archives of physical medicine and rehabilitation

    2007  Volume 88, Issue 3, Page(s) 389–390

    Abstract: A 40-year-old man had an intrathecal morphine-baclofen pump inserted for the treatment of severe dystonia affecting all limbs and severe low back pain. The etiology of his dystonic symptoms, despite thorough investigations, was uncertain. At age 45, the ... ...

    Abstract A 40-year-old man had an intrathecal morphine-baclofen pump inserted for the treatment of severe dystonia affecting all limbs and severe low back pain. The etiology of his dystonic symptoms, despite thorough investigations, was uncertain. At age 45, the patient fell resulting in a cervical spinal cord injury. He underwent C2 through C5 instrumentation and fusion for cervical spine stabilization. Subsequently, an intrathecal morphine-baclofen pump was implanted to control pain and decrease spasticity. The patient ultimately died at age 48 from complications of pneumonia, and an autopsy was performed. Gross pathologic examination revealed that the intrathecal catheter entered the posterior aspect of the lumbar thecal sac, but coursed superiorly in the anterior intradural space. The catheter tip exited the thecal sac in the upper thoracic spine and became embedded in a fibrotic scar. Displacement of the catheter tip of the intrathecal morphine-baclofen pump and subsequent formation of scar tissue resulted in decreased drug delivery, contributing to diminished pain control and functional status. Catheter displacement and epidural scar formation must be considered as a potential cause of ineffective pain control and decreased functional status in patients with intrathecal morphine-baclofen pumps.
    MeSH term(s) Adult ; Analgesics, Opioid/administration & dosage ; Baclofen/administration & dosage ; Catheters, Indwelling/adverse effects ; Cicatrix/complications ; Dystonia/drug therapy ; Equipment Failure Analysis ; Foreign-Body Migration/complications ; Humans ; Infusion Pumps, Implantable/adverse effects ; Injections, Spinal/instrumentation ; Low Back Pain/drug therapy ; Male ; Morphine/administration & dosage ; Muscle Relaxants, Central/administration & dosage
    Chemical Substances Analgesics, Opioid ; Muscle Relaxants, Central ; Morphine (76I7G6D29C) ; Baclofen (H789N3FKE8)
    Language English
    Publishing date 2007-03
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 80057-0
    ISSN 1532-821X ; 0003-9993
    ISSN (online) 1532-821X
    ISSN 0003-9993
    DOI 10.1016/j.apmr.2006.12.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Oxygen consumption of the semi-terrestrial crab Pachygrapsus marmoratus in relation to body mass and temperature: an information theory approach

    Katsanevakis, Stelios / George Verriopoulos / John Xanthopoulos / Nikos Protopapas

    Marine biology. 2007 Mar., v. 151, no. 1

    2007  

    Abstract: ... between 43 mg and 18.0 g, and five test temperatures were used between 13.5 and 28.0°C. Six candidate ... for many other marine invertebrates (at normal temperatures). Q 10 values were relatively low, indicating wide thermal ...

    Abstract Pachygrapsus marmoratus is a semi-terrestrial crab and the most common grapsid crab in the intertidal belt of rocky shores throughout the Mediterranean Sea, Black Sea and northeastern Atlantic. In this study, the combined effects of temperature (T), body mass (M), and sex (S) on the routine oxygen consumption rate (R) in P. marmoratus were quantified. The blotted wet body mass of the specimens ranged between 43 mg and 18.0 g, and five test temperatures were used between 13.5 and 28.0°C. Six candidate models that reflected different assumptions regarding the dependence of R on S and T were compared. Model selection was based on Kullback–Leibler’s information theory and Akaike’s information criterion (AIC). The model [Formula: see text] had the highest support by the data (E is the activation energy, B = 8.618 × 10−5 eV K−1 is Boltzmann’s constant, T a is the absolute temperature in Kelvin, and b the allometric scaling exponent); for P. marmoratus it was found that [Formula: see text] No sex dependence of R was supported by the data. Following a multi-model inference (MMI) approach, the mean (± SE) allometric exponent [Formula: see text] was 0.750 (± 0.013) having a 95% (bootstrap) confidence interval of 0.726–0.774. Thus, it was established that P. marmoratus follows Kleiber’s 3/4 law, as seems to be generally true for intertidal crabs. The allometric exponent was independent of temperature as has also been reported for many other marine invertebrates (at normal temperatures). Q 10 values were relatively low, indicating wide thermal tolerance of the species. Model selection based on information theory is recommended for respiration studies, as an effective method in finding a parsimonious approximating model. MMI by model averaging, based on Akaike weights, is an effective way to make robust parameter estimations and deal with model selection uncertainty.
    Keywords activation energy ; allometry ; aquatic invertebrates ; confidence interval ; crabs ; heat tolerance ; littoral zone ; mathematical theory ; models ; oxygen consumption ; temperature ; uncertainty ; Black Sea ; Mediterranean Sea
    Language English
    Dates of publication 2007-03
    Size p. 343-352.
    Publishing place Springer Berlin Heidelberg
    Document type Article
    ZDB-ID 1117-4
    ISSN 1432-1793 ; 0025-3162
    ISSN (online) 1432-1793
    ISSN 0025-3162
    DOI 10.1007/s00227-006-0485-z
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection.

    Papadopoulos, Antonios I / Ferwerda, Bart / Antoniadou, Anastasia / Sakka, Vissaria / Galani, Lambrini / Kavatha, Dimitra / Panagopoulos, Periklis / Poulakou, Garyphalia / Protopapas, Konstantinos / van der Meer, Jos W M / Netea, Mihai G / Giamarellos-Bourboulis, Evangelos J

    Cytokine

    2012  Volume 60, Issue 1, Page(s) 104–107

    Abstract: Objectives: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and ... ...

    Abstract Objectives: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and the risk of severe infection in individuals with human immunodeficiency virus (HIV)-1 infection.
    Methods: The SNP S180L was determined in a cohort of 179 HIV-1 infected Greek patients. Analysis of the prevalence of this SNP in relation to the infectious complications was evaluated.
    Results: One hundred and thirty-two (73.3%) patients were bearing the wild type haplotype, 43 (24%) were heterozygous for the SNP, and four (2.2%) were homozygous for the variant allele. The individuals with a nadir CD4 count <200 cells/mm(3) who carried the 180L variant demonstrated a 4-fold decrease in the odds ratio (OR) for any serious infection compared with those who carried the wild-type 180S genotype (OR 0.58 vs OR 2.6, p=0.016).
    Conclusions: This study suggest a protection effect of the Mal S180L SNP against serious infections in HIV-1 infected individuals with low CD4 cell counts.
    MeSH term(s) Adult ; Amino Acid Substitution ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; Gene Frequency ; Genetic Predisposition to Disease/genetics ; Genotype ; HIV Infections/complications ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/immunology ; Haplotypes ; Humans ; Male ; Membrane Glycoproteins/genetics ; Middle Aged ; Opportunistic Infections/complications ; Opportunistic Infections/genetics ; Opportunistic Infections/immunology ; Polymorphism, Single Nucleotide ; Receptors, Interleukin-1/genetics ; Risk Factors ; Young Adult
    Chemical Substances Membrane Glycoproteins ; Receptors, Interleukin-1 ; TIRAP protein, human
    Language English
    Publishing date 2012-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1018055-2
    ISSN 1096-0023 ; 1043-4666
    ISSN (online) 1096-0023
    ISSN 1043-4666
    DOI 10.1016/j.cyto.2012.05.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.

    Barkauskas, Christina / Mylonakis, Eleftherios / Poulakou, Garyfallia / Young, Barnaby E / Vock, David M / Siegel, Lianne / Engen, Nicole / Grandits, Greg / Mosaly, Nilima R / Vekstein, Andrew M / Rogers, Ralph / Shehadeh, Fadi / Kaczynski, Matthew / Mylona, Evangelia K / Syrigos, Konstantinos N / Rapti, Vasiliki / Lye, David C / Hui, Diong Shiau / Leither, Lindsay /
    Knowlton, Kirk U / Jain, Mamta K / Marines-Price, Rubria / Osuji, Alice / Overcash, J Scott / Kalomenidis, Ioannis / Barmparessou, Zafeiria / Waters, Michael / Zepeda, Karla / Chen, Peter / Torbati, Sam / Kiweewa, Francis / Sebudde, Nicholus / Almasri, Eyad / Hughes, Alyssa / Bhagani, Sanjay R / Rodger, Alison / Sandkovsky, Uriel / Gottlieb, Robert L / Nnakelu, Eriobu / Trautner, Barbara / Menon, Vidya / Lutaakome, Joseph / Matthay, Michael / Robinson, Philip / Protopapas, Konstantinos / Koulouris, Nikolaos / Kimuli, Ivan / Baduashvili, Amiran / Braun, Dominique L / Günthard, Huldrych F / Ramachandruni, Srikanth / Kidega, Robert / Kim, Kami / Hatlen, Timothy J / Phillips, Andrew N / Murray, Daniel D / Jensen, Tomas O / Padilla, Maria L / Accardi, Evan X / Shaw-Saliba, Katy / Dewar, Robin L / Teitelbaum, Marc / Natarajan, Ven / Laverdure, Sylvain / Highbarger, Helene C / Rehman, M Tauseef / Vogel, Susan / Vallée, David / Crew, Page / Atri, Negin / Schechner, Adam J / Pett, Sarah / Hudson, Fleur / Badrock, Jonathan / Touloumi, Giota / Brown, Samuel M / Self, Wesley H / North, Crystal M / Ginde, Adit A / Chang, Christina C / Kelleher, Anthony / Nagy-Agren, Stephanie / Vasudeva, Shikha / Looney, David / Nguyen, Hien H / Sánchez, Adriana / Weintrob, Amy C / Grund, Birgit / Sharma, Shweta / Reilly, Cavan S / Paredes, Roger / Bednarska, Agnieszka / Gerry, Norman P / Babiker, Abdel G / Davey, Victoria J / Gelijns, Annetine C / Higgs, Elizabeth S / Kan, Virginia / Matthews, Gail / Thompson, B Taylor / Legenne, Philippe / Chandra, Richa / Lane, H Clifford / Neaton, James D / Lundgren, Jens D

    Annals of internal medicine

    2022  Volume 175, Issue 9, Page(s) 1266–1274

    Abstract: Background: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection.: Objective: To investigate if ensovibep, in addition to remdesivir and other ... ...

    Abstract Background: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection.
    Objective: To investigate if ensovibep, in addition to remdesivir and other standard care, improves clinical outcomes among patients hospitalized with COVID-19 compared with standard care alone.
    Design: Double-blind, randomized, placebo-controlled, clinical trial. (ClinicalTrials.gov: NCT04501978).
    Setting: Multinational, multicenter trial.
    Participants: Adults hospitalized with COVID-19.
    Intervention: Intravenous ensovibep, 600 mg, or placebo.
    Measurements: Ensovibep was assessed for early futility on the basis of pulmonary ordinal scores at day 5. The primary outcome was time to sustained recovery through day 90, defined as 14 consecutive days at home or place of usual residence after hospital discharge. A composite safety outcome that included death, serious adverse events, end-organ disease, and serious infections was assessed through day 90.
    Results: An independent data and safety monitoring board recommended that enrollment be halted for early futility after 485 patients were randomly assigned and received an infusion of ensovibep (
    Limitation: The trial was prematurely stopped because of futility, limiting power for the primary outcome.
    Conclusion: Compared with placebo, ensovibep did not improve clinical outcomes for hospitalized participants with COVID-19 receiving standard care, including remdesivir; no safety concerns were identified.
    Primary funding source: National Institutes of Health.
    MeSH term(s) Adult ; Designed Ankyrin Repeat Proteins ; Double-Blind Method ; Humans ; Recombinant Fusion Proteins ; SARS-CoV-2 ; Treatment Outcome ; COVID-19 Drug Treatment
    Chemical Substances Designed Ankyrin Repeat Proteins ; Recombinant Fusion Proteins ; ensovibep (PV6AA88RDU)
    Language English
    Publishing date 2022-08-09
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/M22-1503
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection

    Papadopoulos, Antonios I / Ferwerda, Bart / Antoniadou, Anastasia / Sakka, Vissaria / Galani, Lambrini / Kavatha, Dimitra / Panagopoulos, Periklis / Poulakou, Garyphalia / Protopapas, Konstantinos / van der Meer, Jos W.M / Netea, Mihai G / Giamarellos-Bourboulis, Evangelos J

    Cytokine. 2012 Oct., v. 60, no. 1

    2012  

    Abstract: OBJECTIVES: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and ... ...

    Abstract OBJECTIVES: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and the risk of severe infection in individuals with human immunodeficiency virus (HIV)-1 infection. METHODS: The SNP S180L was determined in a cohort of 179 HIV-1 infected Greek patients. Analysis of the prevalence of this SNP in relation to the infectious complications was evaluated. RESULTS: One hundred and thirty-two (73.3%) patients were bearing the wild type haplotype, 43 (24%) were heterozygous for the SNP, and four (2.2%) were homozygous for the variant allele. The individuals with a nadir CD4 count <200cells/mm³ who carried the 180L variant demonstrated a 4-fold decrease in the odds ratio (OR) for any serious infection compared with those who carried the wild-type 180S genotype (OR 0.58 vs OR 2.6, p=0.016). CONCLUSIONS: This study suggest a protection effect of the Mal S180L SNP against serious infections in HIV-1 infected individuals with low CD4 cell counts.
    Keywords HIV infections ; Human immunodeficiency virus ; alleles ; cytokines ; haplotypes ; heterozygosity ; homozygosity ; odds ratio ; patients ; receptors ; risk
    Language English
    Dates of publication 2012-10
    Size p. 104-107.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1018055-2
    ISSN 1096-0023 ; 1043-4666
    ISSN (online) 1096-0023
    ISSN 1043-4666
    DOI 10.1016/j.cyto.2012.05.008
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article: Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection

    Papadopoulos, Antonios I. / Ferwerda, Bart / Antoniadou, Anastasia / Sakka, Vissaria / Galani, Lambrini / Kavatha, Dimitra / Panagopoulos, Periklis / Poulakou, Garyphalia / Protopapas, Konstantinos / van der Meer, Jos W.M. / Netea, Mihai G. / Giamarellos-Bourboulis, Evangelos J.

    Cytokine

    Volume v. 60,, Issue no. 1

    Abstract: OBJECTIVES: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and ... ...

    Abstract OBJECTIVES: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and the risk of severe infection in individuals with human immunodeficiency virus (HIV)-1 infection. METHODS: The SNP S180L was determined in a cohort of 179 HIV-1 infected Greek patients. Analysis of the prevalence of this SNP in relation to the infectious complications was evaluated. RESULTS: One hundred and thirty-two (73.3%) patients were bearing the wild type haplotype, 43 (24%) were heterozygous for the SNP, and four (2.2%) were homozygous for the variant allele. The individuals with a nadir CD4 count <200cells/mm³ who carried the 180L variant demonstrated a 4-fold decrease in the odds ratio (OR) for any serious infection compared with those who carried the wild-type 180S genotype (OR 0.58 vs OR 2.6, p=0.016). CONCLUSIONS: This study suggest a protection effect of the Mal S180L SNP against serious infections in HIV-1 infected individuals with low CD4 cell counts.
    Keywords risk ; cytokines ; patients ; heterozygosity ; HIV infections ; Human immunodeficiency virus ; odds ratio ; homozygosity ; alleles ; receptors ; haplotypes
    Language English
    Document type Article
    ISSN 1043-4666
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top